FDA inspection

Takeda Austria GmbH: FDA inspection ending Nov 12, 2024

FDA inspection 1256112 · Official Action Indicated (OAI) · Linz

Key facts

Inspection ID 1256112
Firm Takeda Austria GmbH
FEI number 3001157285
Address Sankt-Peter-Strase 25
City Linz
Fiscal year 2025
Inspection end date Nov 12, 2024
Classification Official Action Indicated (OAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections